Investigations on Agglomeration and Haemocompatibility of Vitamin E TPGS Surface Modified Berberine Chloride Nanoparticles

Abstract EN

The objective of the present study is to investigate the influence of surface modification on systemic stability of NPs.

Vitamin E TPGS (1% w/v) was used for surface modification of berberine chloride nanoparticles.

Naked and surface modified NPs were incubated in different SBFs (pH 6.8 and 7.4) with or without bile salts and human plasma.

NPs were observed for particle agglomeration and morphology by particle size analyzer and TEM, respectively.

The haemocompatibility studies were conducted on developed NPs to evaluate their safety profile.

The surface modified NPs were stable compared to naked NPs in different SBFs due to the steric stabilization property of vitamin E TPGS.

Particle agglomeration was not seen when NPs were incubated in SBF (pH 6.8) with bile salts.

No agglomeration was observed in NPs after their incubation in plasma but particle size of the naked NPs increased due to adhesion of plasma proteins.

The TEM images confirmed the particle size results.

DSC and FT-IR studies confirmed the coexistence of TPGS in surface modified NPs.

The permissible haemolysis, LDH release, and platelet aggregation revealed that NPs were compatible for systemic administration.

Thus, the study illustrated that the surface modification is helpful in the maintenance of stability of NPs in systemic conditions.